AirSculpt Technologies, Inc. (NASDAQ:AIRS) Sees Large Increase in Short Interest

AirSculpt Technologies, Inc. (NASDAQ:AIRS) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 2,690,000 shares, a growth of 18.0% from the December 15th total of 2,280,000 shares. Approximately 21.6% of the company’s shares are sold short. Based on an average daily volume of 217,100 shares, the days-to-cover ratio is currently 12.4 days.

Wall Street Analyst Weigh In

Several equities analysts have commented on the company. BTIG Research assumed coverage on AirSculpt Technologies in a research report on Thursday, October 17th. They issued a “neutral” rating on the stock. Piper Sandler cut their price target on shares of AirSculpt Technologies from $7.00 to $6.00 and set a “neutral” rating on the stock in a report on Monday, January 6th. Five equities research analysts have rated the stock with a hold rating, According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $5.50.

Insider Buying and Selling

In other news, CEO Dennis Dean sold 24,510 shares of the company’s stock in a transaction that occurred on Friday, November 15th. The stock was sold at an average price of $6.54, for a total transaction of $160,295.40. Following the transaction, the chief executive officer now owns 582,052 shares of the company’s stock, valued at approximately $3,806,620.08. This represents a 4.04 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 78.30% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On AirSculpt Technologies

Several large investors have recently modified their holdings of the business. Barclays PLC boosted its stake in shares of AirSculpt Technologies by 227.0% during the third quarter. Barclays PLC now owns 19,100 shares of the company’s stock valued at $97,000 after purchasing an additional 13,259 shares in the last quarter. Geode Capital Management LLC boosted its position in AirSculpt Technologies by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 355,540 shares of the company’s stock valued at $1,803,000 after acquiring an additional 21,339 shares in the last quarter. Finally, SW Investment Management LLC boosted its position in AirSculpt Technologies by 5.0% during the 2nd quarter. SW Investment Management LLC now owns 4,500,000 shares of the company’s stock valued at $18,000,000 after acquiring an additional 213,677 shares in the last quarter. Institutional investors own 91.54% of the company’s stock.

AirSculpt Technologies Trading Down 1.4 %

AIRS opened at $4.93 on Friday. The company has a quick ratio of 0.51, a current ratio of 0.51 and a debt-to-equity ratio of 0.80. The stock’s fifty day moving average is $6.23 and its two-hundred day moving average is $5.26. The company has a market capitalization of $285.35 million, a P/E ratio of -35.21 and a beta of 1.71. AirSculpt Technologies has a 52 week low of $2.92 and a 52 week high of $9.20.

AirSculpt Technologies (NASDAQ:AIRS) last posted its quarterly earnings results on Friday, November 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.05). AirSculpt Technologies had a positive return on equity of 2.22% and a negative net margin of 4.13%. The firm had revenue of $42.55 million for the quarter, compared to the consensus estimate of $42.49 million. During the same period in the previous year, the company posted ($0.01) EPS. Analysts forecast that AirSculpt Technologies will post 0.01 earnings per share for the current year.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc, together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure.